טוען...
From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma
Initially identified as a T cell and mast cell growth factor, interleukin (IL)-9 has long been recognized as an important mediator of asthma. Recently, accumulating results from transgenic mice demonstrated that systemic or lung-specific overexpression of IL-9 caused asthma-associated symptoms. More...
שמור ב:
| הוצא לאור ב: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347659/ https://ncbi.nlm.nih.gov/pubmed/28352305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|